The use of SSAs (30% in the ACRO vs 37% in the ACRO-DM group, P = .055) and GHRAs (6% in the ACRO vs 10% in the ACRO-DM group, P = .063) showed a trend for a higher frequency in the ACRO-DM group (see Table 3 ).
← all excerpts
Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly.
1
—
—